miR-34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1.

Zhou, Haibo; Yang, Li; Xu, Xinhua; Lu, Mingqian; Guo, Rong; Li, Daojun; Huang, Qiao; Liu, Yang; Deng, Glenn; Xu, Yalin

Zhou, Haibo; Yang, Li; Xu, Xinhua; Lu, Mingqian; Guo, Rong; Li, Daojun; Huang, Qiao; Liu, Yang; Deng, Glenn; Xu, Yalin.

Afiliação

Zhou H; Institute of Oncology, The First College of Clinical Medical Science, Yichang Central People's Hospital Affiliated to China Three Gorges University, Yichang, Hubei 443000, P.R. China.
Yang L; Department of Thyroid and Breast, The First College of Clinical Medical Science, Yichang Central People's Hospital Affiliated to China Three Gorges University, Yichang, Hubei 443000, P.R. China.
Xu X; Institute of Oncology, The First College of Clinical Medical Science, Yichang Central People's Hospital Affiliated to China Three Gorges University, Yichang, Hubei 443000, P.R. China.
Lu M; Institute of Oncology, The First College of Clinical Medical Science, Yichang Central People's Hospital Affiliated to China Three Gorges University, Yichang, Hubei 443000, P.R. China.
Guo R; Institute of Oncology, The First College of Clinical Medical Science, Yichang Central People's Hospital Affiliated to China Three Gorges University, Yichang, Hubei 443000, P.R. China.
Li D; Institute of Oncology, The First College of Clinical Medical Science, Yichang Central People's Hospital Affiliated to China Three Gorges University, Yichang, Hubei 443000, P.R. China.
Huang Q; Institute of Oncology, The First College of Clinical Medical Science, Yichang Central People's Hospital Affiliated to China Three Gorges University, Yichang, Hubei 443000, P.R. China.
Liu Y; Institute of Oncology, The First College of Clinical Medical Science, Yichang Central People's Hospital Affiliated to China Three Gorges University, Yichang, Hubei 443000, P.R. China.
Deng G; School of Medicine, Stanford University, Stanford, CA 94305, USA.
Xu Y; Advanced Gene Diagnostics, Inc. Tsinghua Science Park, Yichang, Hubei 443001, P.R. China.